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Purpose: To determine whether insulin-like growth factor
(IGF-1) affects transforming growth factor (TGF- ) β -
mediated fibronectin accumulation in human lens epithelial
cell line (HLE B-3) cells. Materials and Methods: HLE
B-3 cells were incubated for 24 hours with TGF- (10 β ng/
mL), IGF-1 (10 ng/mL), or both. Expression of the fibron-
ectin gene was determined using a real-time reverse tran-
scriptase-polymerase chain reaction (RT-PCR). Fibronectin
levels were examined using western blot analysis and
immunofluorescence staining. Results: Expression of the
fibronectin gene was not different between the TGF-β
/IGF-1 treated group and the TGF- treated group ( β p =
0.116). However, western blot analysis demonstrated de-
creased fibronectin levels in human lens epithelial cells
treated with TGF- and IGF-1 compared to those treated β
with TGF- only ( β p < 0.01). Immunofluorescence staining
disclosed inhibition of TGF- -induced fibronectin in the β
presence of IGF-1. Conclusion: This study suggests that
IGF-1 counteracts TGF- -mediated fibronectin accumula β -
tion in human lens epithelial cells.
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INTRODUCTION
Transforming growth factor (TGF- ) has been β
shown to induce epithelial-mesenchymal transfor-
mation for in vitro subcapsular cataracts. It induces
both morphological changes (spindle cell formation,
capsular wrinkling, extracellular matrix accumula-
tion) as well as the molecular markers (type I and
III collagen, laminin, alpha-smooth muscle actin,
fibronectin, and tenascin) that are characteristic of
subcapsular cataracts.
1-4 TGF- is also now being β
examined as a causative factor in posterior capsule
opacification, another growth condition of the lens
which involves transdifferentiation of lens epithelial
cells remaining after cataract surgery.
5
Insulin-like growth factor (IGF-1) is implicated
in mechanisms involving lens polarization, pro-
liferation, and differentiation.
6,7 However, no
studies have demonstrated the effects of IGF-1 on
fibronectin accumulation in human lens epithelial
cells. The present study was undertaken to
investigate the role of IGF-1 in the accumulation
of TGF- -mediated fibronectin in human lens β
epithelial cells.
MATERIALS AND METHODS
Cell culture and treatment
Human lens epithelial cells (HLE B-3) were
provided by Usha Andley, Ph.D., and maintained
as previously described.
8 The HLE B-3 cell
cultures were plated in a 60 mm culture dish,
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allowed to reach 75 - 80% confluence, and the
serum was then starved for 24 hours. Cell
cultures were treated with 10 ng/mL of TGF- 1, β
10 ng/mL of IGF-1 (R&D Systems, Minneapolis,
MN, USA), or both in a serum free media. The
treated cells were compared with control cultures
that were incubated under identical conditions,
but in the absence of TGF- 1 or IGF-1. After a 24 β
hour treatment, total RNA was isolated from the
HCE B-3 cells using TRIzol as the extraction
reagent (Gibco-Invitrogen, Carlsbad, CA, USA).
9
Cells were used at passage five for all ex-
periments.
Reverse transcription
cDNA synthesis (SuperScript III Reverse
Transcriptase; Gibco-Invitrogen) required the use
of 1 g total RNA. μ
10 Reverse-transcription pro-
ducts were then ready for use in real-time
polymerase chain reaction (PCR) preparations.
From the 20 L total reverse transcription volume, μ
1 L was used for each PCR amplification. μ
Real-time PCR
Real-time PCR amplification was performed in
the presence of double-labeled fluorogenic probes
(TaqMan probes; PE-Applied Biosystems, Foster
City, CA, USA) that allow real-time relative
quantification of gene expression. All probes used
in this study were purchased from PE-Applied
Biosystems. Amplification was performed in
triplicate with 1 L of cDNA in a total volume of μ
50 L ( μ TaqMan chemistry; Applied Biosystems).
Assays were performed using an ABI Prism 7700
Sequence Detection System (Applied Biosystems).
To evaluate relative quantification, the efficiency
of the target gene amplification was compared
with the efficiency of the GAPDH amplification.
11
A non-template control was included in all
experiments performed with real-time PCR to
evaluate DNA contamination of the reagents used
for amplification. None of the experiments
resulted in a positive signal from the non-
template control. The data were represented as
the mean ± SD for the three independent
experiments.
Western blot analysis
HLE B-3 cells were lysed in buffer (25 mM
HEPES pH 7.5, 0.3 M NaCl, 1.5 mM MgCl2, 0.2
mM EDTA, 0.05% Triton X-100, 0.5 mM DL-
Dithiothreitol, 0.4 mM PMSF, 2 g/mL leupeptin, μ
and 1 g/mL pepstatin A). After centrifugation μ
for 10 min at 1200 rpm, 20 g of cellular protein μ
was loaded onto 10% SDS-polyacrylamide gels.
The protein bands were then transferred
electrophoretically to Immobilion
TM-P (Millipore
corp., Bedford, MA, USA) PVDF membranes. The
membranes were incubated with blocking
solution (TBS-Tween/5% skim dry milk) and
incubated with rabbit anti-fibronectin antibody (1
: 1000 dilution; Sigma Chemical Co., St Louis, MO,
USA) overnight at 4℃. After removing the
antibodies and washing the reactive proteins, the
membrane was treated with peroxidase-con-
jugated anti-rabbit IgG (1: 5000 dilution; Amersham
Pharmacia Biotech, Buckinghamshire, England).
Detection was carried out using enhanced
chemiluminescence (ECL) detection reagents
(Amersham Pharmacia Biotech) on Hyperfilm
ECL (Amersham Pharmacia Biotech). -actin was β
used as an endogenous reference to determine the
integrity of the protein in each sample. Each band
was quantified by densitometric scanning of the
gels. Data were presented as the mean ± SD of the
three independent experiments.
Immunofluorescence
HLE B-3 cells were fixed for 5 min in 3.7%
formaldehyde and then permeabilized in PBS
containing 0.5% Triton-X100 for 5 min. Following
two 5 min rinses with PBS (pH 7.4), cells were
incubated with rabbit anti-fibronectin antibody (1
: 100 dilution; Sigma Chemical Co.) overnight at
4℃. Cells were washed twice with PBS for 5
min each and then followed by incubation in
TRITC-conjugated donkey anti-rabbit IgG (1 : 1000
dilution; Sigma Chemical Co.) for 1 hour at
room temperature. Cells were washed with PBS,
applied to the slides, and photographed under a
Zeiss Axiophot fluorescence microscope. Results
are representative of at least three independent
experiments.IGF-1 Counteracts TGF- Induced Fibronectin β
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Statistics
Differences between measured mRNA and
protein levels were statistically assessed using an
independent t-test with SPSS (version 12). All tests
used an level of 0.05. α
RESULTS
Fibronectin mRNA expression in HLE B-3 cells
Expression of the fibronectin gene transcripts in
HLE B-3 cells for four groups (Table 1) was
determined by real-time PCR (Fig. 1). The use of
real-time PCR demonstrated that the level of
fibronectin gene expression significantly increased
following TGF- 1 treatment ( β p < 0.01). However,
no change was detected in the expression of the
fibronectin mRNA with the IGF-1 treatment in
HLE B-3 cells. The amount of fibronectin
transcripts was not significantly different between
the control group and the IGF-1 treatment group
(p = 0.305). The level of fibronectin gene expression
remained essentially unaltered following 24 hours
of treatment with TGF- 1 and IGF-1 when β
compared to treatment with TGF- 1 only ( β p =
0.116). These results indicate that IGF-1 did not
affect fibronectin mRNA expression in human
lens epithelial cells.
Western blot analysis for fibronectin in HLE B-3
cells
Western blot analysis was performed on total
proteins obtained from HLE B-3 cells to determine
the effects of TGF- 1, IGF-1, or both on fibronectin β
protein levels. Equivalent -actin (an internal β
housekeeping control for western blot analysis)
bands were obtained. As shown in Fig. 2,
fibronectin levels in HLE B-3 cells increased after
24 hours of TGF- 1 treatment ( β p < 0.01) when
compared to untreated control cells. The amount
of fibronectin was not significantly different
between control and IGF-1 treatment groups (p =
Table 1. Lists Relative Fibronectin Expression Compared to the Control at mRNA and Protein Levels in Lens
Epithelial Cells Following Treatment with TGF- 1, IGF-1, or Both β
Group Treatment Real-time PCR Western blot analysis Immunofluorescence staining
I Control (media) 1 ± 0.03 1 ± 0.14
II TGF- 1 (10 β ng/mL) 2.997 ± 0.21 (p < 0.01) 8.4 ± 0.25 (p < 0.01) Significant increase
III IGF-1 (10 ng/mL) 1.03 ± 0.04 (p = 0.305) 1.35 ± 0.032 (p = 0.135) No definite change
IV TGF- 1 (10 β ng/mL)
and IGF-1 (10 ng/mL)
2.86 ± 0.16 (p < 0.01) 5.4 ± 0.17 (p < 0.01) Slight increase
Difference between Group II
and IV
p = 0.116 p < 0.01 Group IV shows less fluorescence
compared to Group II
Data is expressed as the mean ± SD.
Fig. 1. The real-time polymerase chain reaction (PCR)
demonstrated that no change was detected in the
expression of the fibronectin gene following 24 hour
treatment with insulin-like growth factor (IGF)-1 in
human lens epithelial cells (HLE B-3). The amount of
fibronectin transcripts significantly increased following
treatment with TGF- 1. There was no significant difference β
in the amount of fibronectin (FN) gene transcripts
between control and IGF-1 treatment groups, and
between TGF- 1 only and TGF- 1 and IGF-1 treatment β β
groups. The graphs show the mean values of the three
independent experiments with the error bars repre-
senting the standard deviation.So-Hyang Chung, et al.
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0.135). However, after treatment with TGF- 1 and β
IGF-1, fibronectin decreased when compared to
cells treated with TGF- 1 only. Quantification of β
each band through densitometric scanning showed
a significant decrease in fibronectin for lens
epithelial cells treated with TGF- 1 and IGF-1 β
when compared to cells treated with TGF- 1 only β
(p < 0.01) (Fig. 2). These results indicate that IGF-1
did not just affect fibronectin protein levels, but
also decreased TGF- 1-mediated fibronectin β
accumulation in human lens epithelial cells.
Immunofluorescence staining for fibronectin in
HLE B-3 cells
Immunofluorescence staining of HLE B-3 cells
using anti-fibronectin antibodies indicated that
groups treated with TGF- 1 (Fig. 3B) demon β -
strated more fluorescence when compared to the
untreated control cells (Fig. 3A). However,
following treatment with TGF- 1 and IGF-1 (Fig, β
3D), less fluorescence was detected when com-
pared to cells treated with TGF- 1 only (Fig, 3B). β
These immunofluorescence findings are consistent
with the results of the western blot analysis.
DISCUSSION
The pathogenesis of subcapsular cataracts,
which includes anterior polar cataracts and
after-cataracts, is believed to occur through the
aberrant transdifferentiation of lens epithelial cells
(LECs) into myofibroblast-like cells that may be
responsible for the abnormal accumulation of
extracellular matrix.
4,12-14 Inappropriate TGF-β
signaling in the anterior lens epithelial cells results
in an epithelial-mesenchymal transition (EMT) that
bears morphological and molecular resemblance
to human cataracts, including anterior subcapsular
(ASC) and posterior capsule opacification (PCO;
also known as secondary cataract or after-cataract),
which occurs following cataract surgery.
15
According to studies using transgenic mice,
cataracts induced by the expression of TGF- 1 β
have many similarities to human capsulolenticular
cataracts, which include anterior subcapsular
cataracts and anterior polar cataracts.
16 These
lenticular plaques are derived from the lens
epithelium, and are comprised of spindle-shaped
cells interspersed with accumulations of extracel-
lular matrix. The results from our study demon-
strate that TGF- treatment of human lens β
epithelial cells (HLE-B3) induces fibronectin
accumulation. Previous studies have demonstrated
that fibronectin has been detected among
subcapsular plaques in rat lens cultured with TGF-
as well as in LECs transformed into mesenchymal- β
like cells in type I collagen gel.
4,17 Lee and Joo
have shown, using western blot analysis, that
TGF- significantly increases fibronectin protein β
levels in bovine LECs.
3 Our data also demon-
strated that TGF- significantly increases fibronectin β
protein levels for in vitro human lens epithelial
cells.
Our results demonstrate the role of IGF-1 in
TGF- -mediated fibronectin accumulation in β
Fig. 2. IGF-1 counteracts TGF- -mediated fibronectin β
accumulation in the human lens epithelial cell line (HLE
B-3 cells). HLEB-3 cells in serum-free media were
incubated for 24 hours with TGF- 1 (10 β ng/mL), IGF-1
(10 ng/mL), or both. Fibronectin levels increased fol-
lowing treatment with TGF- 1 (10 β ng/mL) in the western
blot analysis. However, fibronectin (FN) levels decreased
after treatment with TGF- 1 (10 β ng/mL) and IGF-1 (10
ng/mL) when compared to treatment with TGF- 1 (10 β
ng/mL) only. Values in these graphs represent the mean
of the three experiments and error bars represent the
standard deviation. Values were normalized to the
density of the respective -actin band. βIGF-1 Counteracts TGF- Induced Fibronectin β
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human lens epithelial cells, although IGF-1 has
been reported to be involved in lens cell pro-
liferation and differentiation.
6,7 The effects of
IGF-1 on fibronectin accumulation have not
previously been recognized in lens epithelial cells.
Fibronectin expression did not significantly
increase due to IGF-1 at both mRNA and protein
levels. However, western blot analysis showed
reduced fibronectin protein levels with the TGF-β
and IGF-1 treatment when compared to the TGF-
only treatment group. Immunofluorescence data β
using anti-fibronectin antibodies also showed
decreased fluorescence with the TGF- and IGF-1 β
treatment when compared to the TGF- only β
treatment group. IGF-1 and TGF- costimulation β
has been reported to markedly increase extracellular
matrix proteins (collagen type I, fibronectin, and
plasminogen activator inhibitor-1) in keloid
fibroblasts when compared with the TGF- only β
culture, although IGF-1 treatment alone had no
stimulatory effect.
18 These results indicate different
effects of IGF-1 on TGF- -mediated fibronectin β
accumulation based on the cell type and organ.
By using a real-time RT-PCR, we demonstrated
that IGF-1 did not alter the expression of the
fibronectin gene in human lens epithelial cells.
Fibronectin gene expression levels were not
significantly different between the TGF- 1/IGF-1 β
treatment group and the TGF- 1 only treatment β
group. However, following the TGF- 1 and IGF-1 β
treatment, fibronectin protein levels were
significantly reduced when compared to the TGF-
1 only treatment. We speculate that cross-com β -
munication between intracellular signal transduc-
Fig. 3. Comparative fluorescent micrographs showing IGF-1 inhibition of TGF- -mediated fibronectin accumulation in β
HLE B-3 cells. Cells were maintained (A) in serum free media alone; (B) treated with 10 ng/mL TGF- 1 for 24 hr; (C) β
treated with 10 ng/mL IGF-1 for 24 hr; (D) treated with 10 ng/mL IGF-1 in the presence of 10 ng/mL TGF- 1 for 24 β
hr. The bar represents 50 m in A-D. μSo-Hyang Chung, et al.
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tion pathways of TGF- 1 and IGF-1 may cause a β
discrepancy between mRNA and protein levels.
Intracellular signal molecules from IGF-1 may
affect the translation level of increased fibronectin
mRNA or increased fibronectin gene stability from
TGF- 1. Further studies are needed to investigate β
the molecular signaling mechanisms between
TGF- 1 and IGF-1. β
In summary, we have reported that IGF-1
counteracts TGF- -mediated fibronectin accumu β -
lation in human lens epithelial cells. IGF-1 may
have therapeutic uses due to its inhibitory effect
on fibronectin accumulation in human lens
epithelial cells.
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